TipRanks
Go Ultimate55% OFF

Lung Kee (Bermuda) Holdings Limited (0255) AI Stock Analysis

HK:0255

Lung Kee (Bermuda) Holdings Limited

(HKEX:0255)

Select Model
Rating:59Neutral
Price Target:HKD 1.50â–²(7.91% Upside)
Action:downgraded
Date:08/07/26

The score is driven primarily by the strong balance sheet and positive operating cash flow, which help offset weak revenue trends and recent net losses. Technicals are neutral, while valuation is mixed because the high dividend yield is counterbalanced by a negative P/E and ongoing earnings weakness.

Positive Factors
Strong balance sheet (low leverage)Extremely low leverage gives the company durable financial flexibility: it lowers solvency risk, preserves borrowing capacity, and allows management to fund operations, capex or working-capital needs while executing turnaround measures over the next several months.
Negative Factors
Three years of net lossesSustained net losses erode retained earnings and limit financial options: they can constrain reinvestment, pressure dividend sustainability, and force cost-cutting or asset sales if profitability isn't restored within a medium-term horizon.

Lung Kee (Bermuda) Holdings Limited (0255) vs. iShares MSCI Hong Kong ETF (EWH)

-30%-20%-10%0%10%20%HK:0255-13.88%EWH+8.19%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
HKD 881.27M
Dividend Yield
14.39%
Average Volume (3M)
27.96K
Price to Earnings (P/E)
-29.9
Beta (1Y)
0.32
Revenue Growth
-17.65%
EPS Growth
-538.68%
Country
Hong Kong
Employees
2,800
Sector
Industrials
Sector Strength
63
Industry
Industrial - Machinery

Lung Kee (Bermuda) Holdings Limited Business Overview & Revenue Model

Company Description

Lung Kee Group Holdings Limited, an investment holding company, manufactures and markets mould bases and related products in the People's Republic of China and internationally. The company also engages in the property investment and corporate managem...

How the Company Makes Money

The company primarily makes money by selling mould bases and related standard mould components to mould makers and manufacturers that require these parts as inputs for producing injection moulds and die-casting moulds. Revenue is generally generated...

Lung Kee (Bermuda) Holdings Limited Financial Statement Overview

Summary

Mixed fundamentals: the balance sheet is very strong with negligible leverage, and cash flow remains positive despite losses, but revenue has fallen sharply and profitability has weakened. The financial score is lifted by solvency and cash generation, while persistent net losses and margin volatility limit the overall rating.

Income Statement

42Neutral

Balance Sheet

88Very Positive

Cash Flow

65Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.20B1.32B1.55B1.45B1.60B2.27B
Gross Profit210.41M268.35M951.69M263.90M398.00M777.07M
EBITDA85.80M108.90M148.58M56.87M180.74M472.05M
Net Income-29.43M-22.62M-13.67M-72.43M15.81M227.84M
Balance Sheet
Total Assets1.76B1.82B1.97B2.09B2.30B2.75B
Cash, Cash Equivalents and Short-Term Investments649.71M588.63M546.65M428.76M536.64M833.59M
Total Debt2.79M4.36M7.83M6.57M9.56M9.02M
Total Liabilities249.92M266.93M298.08M294.22M314.90M474.46M
Stockholders Equity1.51B1.55B1.67B1.80B1.99B2.27B
Cash Flow
Free Cash Flow221.06M173.25M190.82M-35.72M-93.17M168.61M
Operating Cash Flow257.50M213.28M226.34M77.21M89.17M369.94M
Investing Cash Flow-16.31M-27.03M-24.35M-98.07M-170.05M-193.03M
Financing Cash Flow-128.00M-165.69M-67.33M-73.86M-168.90M-277.76M

Lung Kee (Bermuda) Holdings Limited Technical Analysis

Technical Analysis SentimentPositive
Last Price1.39

Price Trends

50DMA1.38Positive
100DMA1.37Positive
200DMA1.34Positive

Market Momentum

MACD-0.00Negative
RSI61.17Neutral
STOCH81.82Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0255, the sentiment is Positive. The current price of 1.39 is above the 20-day moving average (MA) of 1.37, above the 50-day MA of 1.38, and above the 200-day MA of 1.34, indicating a bullish trend. The MACD of -0.00 indicates Negative momentum. The RSI at 61.17 is Neutral, neither overbought nor oversold. The STOCH value of 81.82 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:0255.

Lung Kee (Bermuda) Holdings Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (63)

Financial Indicators

HK:0255 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
HK:3816HK:381666NeutralHKD 2.40B28.0313.60%0.33%37.42%124.96%
Sector *63Neutral$10.79B15.437.44%2.01%2.89%-14.66%
HK:0255HK:025559NeutralHKD 881.27M-29.89-1.92%14.39%-17.65%-538.68%
HK:0838HK:083857NeutralHKD 1.12B4.397.26%6.84%-4.88%-0.62%
HK:2535HK:253551NeutralHKD 1.16B-182.40-2.37%―-31.18%-121.38%
HK:0929HK:092948NeutralHKD 499.82M43.640.61%5.83%23.21%11.11%
HK:0822HK:082246NeutralHKD 259.19M-6.28-3.69%―>-0.01%15.55%

* Industrials Sector Average

Performance Comparison

0%500%1000%HK:0255HK:0822HK:0838HK:0929HK:3816HK:2535Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
HK:0255 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
HK:0255Lung Kee (Bermuda) Holdings Limited1.39-0.21-12.91%
HK:0822Ka Shui International Holdings Limited0.30-0.06-16.67%
HK:0838Eva Precision Industrial Holdings Limited0.63-0.48-43.04%
HK:0929IPE Group Limited0.48-0.28-36.93%
HK:3816KFM Kingdom Holdings Ltd.3.813.37761.17%
HK:2535WK Group (Holdings) Limited0.58-0.18-23.68%

Lung Kee (Bermuda) Holdings Limited Corporate Events

Lung Kee Group Sets August Board Meeting to Approve Interim Results and Consider Dividend

Aug 6, 2026

Lung Kee Group Holdings Limited has scheduled a board meeting for 21 August 2026 in Hong Kong to review and approve the group’s interim results for the six months ended 30 June 2026. The board will also consider the payment of an interim divide...

Lung Kee Group Updates Bermuda Registered Office Address

Jul 20, 2026

Lung Kee Group Holdings Limited has announced a change to the address of its registered office in Bermuda, effective 3 August 2026, relocating to Richmond House on Par-la-Ville Road in Hamilton. The company confirmed that its branch share registrar a...

Lung Kee Shareholders Approve All AGM Resolutions, Endorse Dividend and Capital Mandates

May 18, 2026

Lung Kee Group Holdings Limited reported that shareholders approved all resolutions at its 18 May 2026 annual general meeting, including adoption of the 2025 audited financial statements and a final dividend of HK12 cents per share. The meeting saw f...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 04, 2026